The findings come as welcome news as NSW lockdowns continue – but future cancer treatment patterns will depend on how current infection rates develop.
Promising research shows scientists can identify a key cancer biomarker – PD-L1 – in blood.
Public education and engagement with research can be improved using technology commonly found in computer games.
A low haemoglobin count, older age and high BMI are possible risk factors for developing nerve damage after cancer treatment, a UNSW-led study has found.
People with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict disease risk, a UNSW Sydney study has found.
This World Cancer Day, a range of UNSW Medicine & Health cancer researchers, clinicians and scientists are available for media interviews across all aspects of cancer, from prevention and detection to treatment and survivorship.
A new modelling study led by UNSW predicts demand for cancer surgery will rise by 52 per cent within two decades, with low-income countries bearing the greatest burden.
Biomedical researchers have come up with a novel way to use a beam of light to deliver CRISPR gene therapy molecules targeting illnesses.
Associate Professor Guozhen Liu has been recognised for breakthroughs in individualised treatment for autoimmune diseases and cancer.
A global team of medical researchers led by UNSW have developed a test that could help to predict survival for women diagnosed with ovarian cancer, and pave the way towards personalised treatment.